too early for licensing deal (imo)
good to pay attention to what else is going on coz ATX doesn’t operate in a vacuum. Several FAK inhibitors in development, the one from Verastem oncology looks the most advanced. They also tout theirs as “best in class”!!
too early for licensing deal (imo) good to pay attention to what...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.002(3.45%) |
Mkt cap ! $16.29M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.2¢ | 6.0¢ | $5.2K | 85.85K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 217288 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 169148 | 1 |
View Market Depth
| Last trade - 14.31pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.2¢ |
Change
0.002 ( 6.90 %) |
||||
| Open | High | Low | Volume | ||
| 6.0¢ | 6.2¢ | 6.0¢ | 12993 | ||
| Last updated 11.20am 22/05/2024 ? | |||||
| ATX (ASX) Chart |